General - Press Releases

Date	Title	Company
10-Jul-2023	Armis Named Leader in GigaOm Radar Report for Operational Technology (OT) Security	Businesswire
10-Jul-2023	Zoetis Announces Appointment of Ester Banque as President of U.S. Operations for World Leader in Animal Health	Businesswire
10-Jul-2023	Bacterial Therapeutics Market Analysis Report 2023 - Recent Developments and the Need for Antibiotic Innovation - ResearchAndMarkets.com	Businesswire
10-Jul-2023	FSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stock	Businesswire
10-Jul-2023	CRISPR And Cas Genes Market Research Report 2023 Featuring Top Players - Thermo Fisher Scientific, Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Caribou Biosciences - ResearchAndMarkets.com	Businesswire
10-Jul-2023	Eli Lilly Selects ABEC for World’s Largest Single-Use Biopharmaceutical Manufacturing Facility	Businesswire
10-Jul-2023	Energy Recovery Announces Appointment of Refrigeration, Water Executives to Board of Directors	Businesswire
10-Jul-2023	Starton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma	Businesswire
10-Jul-2023	Bruker Enables Advanced Life-Science and Green-Tech Research in the UK	Businesswire
10-Jul-2023	BeiGene and DualityBio Announce Partnership to Advance Differentiated Antibody Drug Conjugate (ADC) Therapy for Solid Tumors	Businesswire
10-Jul-2023	Switch Therapeutics Appoints Douglas Fambrough, Ph.D., to Board of Directors	Businesswire
10-Jul-2023	Slingshot Biosciences Unveils Revolutionary Fluorescent Protein Control Series to Enhance Flow Cytometry Analysis	Businesswire
10-Jul-2023	Wyss Center Appoints Dr. Craig Cook as New Head of Business Development and Licensing	Businesswire
10-Jul-2023	IAMA Therapeutics Announces Sponsored Research Agreement with The Sapienza University of Rome, Italy	Businesswire
10-Jul-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
10-Jul-2023	Erwiderungsschreiben an die Aktionäre von NYMOX PHARMACEUTICAL CORP („NYMX-Q“)	Businesswire
10-Jul-2023	Lettere di risposta inviate agli azionisti di NYMOX PHARMACEUTICAL CORP ("NYMX-Q")	Businesswire
10-Jul-2023	Lettres de réfutation adressées aux actionnaires de NYMOX PHARMACEUTICAL CORP (« NYMX-Q »)	Businesswire
10-Jul-2023	Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UK	Businesswire
10-Jul-2023	Weerleggingsbrieven verstuurd naar aandeelhouders van NYMOX PHARMACEUTICAL CORP ("NYMX-Q")	Businesswire